Elafin, via immune-derived miRNAs and cytokine, activates leptin sensitivity and expression that subsequently inhibit food consumption, obesity, hyperglycemia, and liver steatosis in HFD-treated male mice. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.